Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01198067 · OUTCOME

Changes in Waldestrom Biomarkers

Pomalidomide in Treating Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia · Source last updated 2025-09-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
IgM Protein mg/dL
Interval / dispersion
Standard Deviation
Time frame
Through Study Completion (Avg. 1 Year)

What was measured

Average Reduction in IgM Protein mg/dL from Cycle 1 thru Study

Groups in this outcome

Cohort 2

2mg Pomolidomide per day per Cycle (Cycle = 28 days)

Cohort 3

1mg Pomolidomide per day per Cycle (Cycle = 28 days)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Cohort 23
Cohort 36

Reported measurements

Source class 1
Values in IgM Protein mg/dL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Cohort 2493955Not reportedNot reportedNot reported
Cohort 312522011Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        955
        value
        493
      2. group Id
        OG001
        spread
        2011
        value
        1252
denoms
  1. counts
    1. group Id
      OG000
      value
      3
    2. group Id
      OG001
      value
      6
    units
    Participants
description
Average Reduction in IgM Protein mg/dL from Cycle 1 thru Study
dispersion Type
Standard Deviation
groups
  1. description
    2mg Pomolidomide per day per Cycle (Cycle = 28 days)
    id
    OG000
    title
    Cohort 2
  2. description
    1mg Pomolidomide per day per Cycle (Cycle = 28 days)
    id
    OG001
    title
    Cohort 3
param Type
MEAN
reporting Status
POSTED
time Frame
Through Study Completion (Avg. 1 Year)
title
Changes in Waldestrom Biomarkers
type
SECONDARY
unit Of Measure
IgM Protein mg/dL

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice